Cargando…

Hepatitis B Serology in Patients with Rheumatic Diseases

BACKGROUND: Only limited data are available on the prevalence of hepatitis B in patients with proven rheumatic diseases and thus the risk of reactivation under immunosuppressive therapy. OBJECTIVE: To analyse hepatitis B serology in patients with rheumatic diseases prior to therapy. METHOD: In total...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feuchtenberger, Martin, Schäfer, Arne, Philipp Nigg, Axel, Rupert Kraus, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039958/ https://www.ncbi.nlm.nih.gov/pubmed/27708728 http://dx.doi.org/10.2174/1874312901610010039

Ejemplares similares

Rate of Proven Rheumatic Diseases in a Large Collective of Referrals to an Outpatient Rheumatology Clinic Under Routine Conditions
por: Feuchtenberger, Martin, et al.
Publicado: (2016)

TNF inhibitors significantly attenuate the humoral immune response to COVID-19 vaccination in patients with rheumatoid arthritis
por: Schäfer, Arne, et al.
Publicado: (2023)

Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis
por: Schäfer, Arne, et al.
Publicado: (2022)

Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis
por: Feuchtenberger, Martin, et al.
Publicado: (2022)

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients
por: Charpin, Caroline, et al.
Publicado: (2009)

Treatment of rheumatic diseases and hepatitis B virus coinfection
por: Felis-Giemza, Anna, et al.
Publicado: (2014)

SEROLOGICAL STUDIES IN RHEUMATIC FEVER : I. THE "PHASE" REACTION AND THE DETECTION OF AUTOANTIBODIES IN THE RHEUMATIC STATE
por: Fischel, Edward E., et al.
Publicado: (1949)

Frequency of Regulatory T Cells is Not Affected by Transient B Cell Depletion Using Anti-CD20 Antibodies in Rheumatoid Arthritis
por: Feuchtenberger, Martin, et al.
Publicado: (2008)

Serological epitope profile of anti-Ro52–positive patients with systemic autoimmune rheumatic diseases
por: Infantino, Maria, et al.
Publicado: (2015)

Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy
por: Canzoni, Marco, et al.
Publicado: (2020)

Efficacy of serology driven “test and treat strategy” for eradication of H. pylori in patients with rheumatic disease in the Netherlands
por: de Leest, H. T. J. I., et al.
Publicado: (2011)

Serological and molecular diagnosis of hepatitis B virus
por: Durgadevi, S, et al.
Publicado: (2012)

Hepatitis B serological markers and plasma DNA concentrations
por: Price, Huw, et al.
Publicado: (2017)

Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
por: Koutsianas, Christos, et al.
Publicado: (2020)

Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B
por: Xu, Bin, et al.
Publicado: (2018)

Serological Evidence of Immune Priming by Group A Streptococci in Patients with Acute Rheumatic Fever
por: Raynes, Jeremy M., et al.
Publicado: (2016)

Serology based disease status of Pakistani population infected with Hepatitis B virus
por: Alam, Muhammad Masroor, et al.
Publicado: (2007)

Virological and serological features of acute hepatitis B in adults
por: Du, Xiaofei, et al.
Publicado: (2017)

For patients with rheumatic disease and hepatitis C infection: the end of interferon
por: Calabrese, Leonard H, et al.
Publicado: (2015)

Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease
por: Kraus, Courtney L., et al.
Publicado: (2012)

Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis
por: Auroux, Maxime, et al.
Publicado: (2022)

Current treatment of hepatitis C-associated rheumatic diseases
por: Ferri, Clodoveo, et al.
Publicado: (2012)

Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort
por: Mauro, Daniele, et al.
Publicado: (2022)

Treatment or Prophylaxis against Hepatitis B Virus Infection in Patients with Rheumatic Disease Undergoing Immunosuppressive Therapy: An Update
por: Stasi, Cristina, et al.
Publicado: (2021)

Evaluation of hepatitis A, B, and C serology in patients with cirrhosis and intensive alcohol consumption
por: Vatansever, Sezgin, et al.
Publicado: (2018)

Evolution of hepatitis B serological markers in HIV coinfected patients: a case study
por: Toscano, ALCC, et al.
Publicado: (2017)

Serological and vaccine evaluation for hepatitis B among Community Health Workers
por: Amaral, Tauana de Souza, et al.
Publicado: (2023)

A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease
por: da Silva, Elizabeth N., et al.
Publicado: (2018)

The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?
por: Lall, Sujata, et al.
Publicado: (2020)

Rheumatic diseases, rheumatism and arthritis
por: Brugsch, Heinrich Georg, 1903-
Publicado: (1957)

Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis
por: Bender, Tim T. A., et al.
Publicado: (2020)

Serological and Molecular Characterization of Hepatitis B Virus Infection in Gastric Cancer
por: Li, Mengge, et al.
Publicado: (2022)

Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa
por: Ben Halima, Samar, et al.
Publicado: (2010)

Retinal Vessel Diameters and Physical Activity in Patients With Mild to Moderate Rheumatic Disease Without Cardiovascular Comorbidities
por: Deiseroth, Arne, et al.
Publicado: (2018)

Protective Role of Rheumatic Diseases Against Hepatitis B Virus Infection and Human Leukocyte Antigen B27 Highlighted
por: Ye, Junna, et al.
Publicado: (2022)

Studies on the serological markers for hepatitis B virus infection among type 2 diabetic patients
por: Ndako, James A., et al.
Publicado: (2021)

Serological Evidence of Hepatitis B and E and Dengue Coinfection in Chadian Patients and Impact on Lipidemia Profile
por: Djasrabe, Alexandre Kanga, et al.
Publicado: (2022)

Regulatory B cells in autoimmune rheumatic diseases
por: Sakkas, Lazaros I.
Publicado: (2017)

Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women
por: Aba, Henrietta Oneh, et al.
Publicado: (2016)

Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer.
por: Sparos, L., et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_28tu17tbr7dkjjrt942lhlbmjp